Recommendations for CIRM from Blue-ribbon Panel
Here is a list of the recommendations of the blue-ribbon panel concerning the California stem cell agency.
• Build on CIRM’s previous and ongoing investments
• Sharpen the focus on meaningful, targeted excellence required for global leadership in
the development of innovative treatments based on regenerative medicine
• Sustain a vigorous program of fundame…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.